[go: up one dir, main page]

NO20014192D0 - Fremgangsmåte ved ökning av benvolum ved å anvende ikke naturlig forekommende EP-selektive agonister - Google Patents

Fremgangsmåte ved ökning av benvolum ved å anvende ikke naturlig forekommende EP-selektive agonister

Info

Publication number
NO20014192D0
NO20014192D0 NO20014192A NO20014192A NO20014192D0 NO 20014192 D0 NO20014192 D0 NO 20014192D0 NO 20014192 A NO20014192 A NO 20014192A NO 20014192 A NO20014192 A NO 20014192A NO 20014192 D0 NO20014192 D0 NO 20014192D0
Authority
NO
Norway
Prior art keywords
naturally occurring
bone volume
increasing bone
selective agonists
agonists
Prior art date
Application number
NO20014192A
Other languages
English (en)
Other versions
NO20014192L (no
Inventor
James Richard Hartke
Mark Walden Lundy
Mitchell Anthony Delong
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO20014192D0 publication Critical patent/NO20014192D0/no
Publication of NO20014192L publication Critical patent/NO20014192L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/559—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing hetero atoms other than oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20014192A 1999-03-05 2001-08-29 Fremgangsmåte ved ökning av benvolum ved å anvende ikke naturlig forekommende EP1-selektive agonister NO20014192L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12306399P 1999-03-05 1999-03-05
PCT/US2000/005196 WO2000051585A2 (en) 1999-03-05 2000-03-01 Use of a non-naturally-occurring ep1 selective agonist for increasing bone volume

Publications (2)

Publication Number Publication Date
NO20014192D0 true NO20014192D0 (no) 2001-08-29
NO20014192L NO20014192L (no) 2001-11-05

Family

ID=22406507

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014192A NO20014192L (no) 1999-03-05 2001-08-29 Fremgangsmåte ved ökning av benvolum ved å anvende ikke naturlig forekommende EP1-selektive agonister

Country Status (10)

Country Link
EP (1) EP1158969A2 (no)
JP (1) JP2002538105A (no)
AU (1) AU3711900A (no)
CA (1) CA2366755A1 (no)
CO (1) CO5150205A1 (no)
IL (1) IL145128A0 (no)
NO (1) NO20014192L (no)
NZ (1) NZ513828A (no)
PE (1) PE20001552A1 (no)
WO (1) WO2000051585A2 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090074844A1 (en) 2005-04-28 2009-03-19 Ono Pharmaceutical Co., Ltd. Trenadermal absorption preparation
WO2008050848A1 (en) 2006-10-26 2008-05-02 Ono Pharmaceutical Co., Ltd. Adhesive preparation
WO2009133863A1 (ja) 2008-04-28 2009-11-05 国立大学法人浜松医科大学 Ｅｐ１アゴニストを含有してなる免疫増強剤
EP2542263A4 (en) * 2010-03-05 2013-07-31 Univ Rochester EP1 INHIBITION

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3982016A (en) * 1975-08-06 1976-09-21 Pfizer Inc. Bone deposition by 16-aryl-13,14-dihydro-PGE2 p-biphenyl esters
US4621100A (en) * 1981-09-25 1986-11-04 The Upjohn Company Treatment of osteoporosis with prostaglandins
US4812304A (en) * 1984-12-21 1989-03-14 The Procter & Gamble Company Treatment of osteoporosis
WO1992021350A1 (en) * 1991-05-29 1992-12-10 Sepracor, Inc. Combination of nsaids and prostaglandins and uses therefor
JP2001515864A (ja) * 1997-09-09 2001-09-25 ザ プロクター アンド ギャンブル カンパニー 非天然ｆｐ選択的作用薬を使用した骨体積増加方法
WO2000021542A1 (en) * 1998-10-15 2000-04-20 Merck & Co., Inc. Methods for stimulating bone formation
AU3385900A (en) * 1999-03-05 2000-09-21 Procter & Gamble Company, The Method of increasing bone volume using non-naturally-occurring selective fp agonist and dito ep1 agonist prostaglandin derivatives

Also Published As

Publication number Publication date
WO2000051585A2 (en) 2000-09-08
NO20014192L (no) 2001-11-05
IL145128A0 (en) 2002-06-30
WO2000051585A3 (en) 2001-01-25
PE20001552A1 (es) 2001-01-30
CO5150205A1 (es) 2002-04-29
AU3711900A (en) 2000-09-21
CA2366755A1 (en) 2000-09-08
NZ513828A (en) 2001-09-28
EP1158969A2 (en) 2001-12-05
JP2002538105A (ja) 2002-11-12

Similar Documents

Publication Publication Date Title
NO20001171D0 (no) FremgangsmÕte ved økning av benvolum under anvendelse av ikke naturlig forekommende FP-selektive agonister
AU2003239178A1 (en) Method for making tissue and towel products containing crosslinked cellulosic fibers
AU3872300A (en) Polypectomy snare instrument
NO995660D0 (no) Fremgangsmåte ved kommunikasjon og anordning for samme
ZA200107291B (en) Use of xenon for treating neurointoxications.
SG127691A1 (en) Methods and instruments for improving refractive ophthalmic surgery
AU2002341876A1 (en) Methods and devices for treating diseased blood vessels
NO20001870D0 (no) Ny fremgangsmõte for behandling
AU2111500A (en) Bone tissue regenerating composition
AU2001255602A1 (en) Methods for treating bone tumors
DK1228032T3 (da) Præparater, som indeholder hydroxyicosatetraensyrederivater, og fremgangsmåder til anvendelse ved behandling af öjentörhedslidelser
AU2002213114A1 (en) Compositions and methods for reducing gnrh-induced bone loss
NO20014429L (no) Elektropolymeriserbar film, fremgangsmåte ved fremstilling og anvendelse derav
NO20021823L (no) Behandling av emfysem ved bruk av RAR-selektive retinoidagonister
NO20014192D0 (no) Fremgangsmåte ved ökning av benvolum ved å anvende ikke naturlig forekommende EP-selektive agonister
AU2002363167A1 (en) Developer constituents and their use for dying keratin fibers
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
NO20014193D0 (no) Fremgangsmåte ved ökning av benvolum ved å anvende ikke naturlig forekommende FP-selektive agonister og antiresorptiveforbindelser
AU2002353907A1 (en) Methods for treating wounds using melanin and related substances
AU4593799A (en) Composition for cleaning and removing parasites from the hair
AU4206400A (en) Methods and apparatus for brokering transactions
AU2001244025A1 (en) Method for predicting the results of cosmetic surgery
AU2001253560A1 (en) Methods of treatment
AU7416900A (en) Physical method for bleaching keratin fibers
AU2002342188A1 (en) Methods and compositions for treating flavivirus-mediated disease

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application